Global Bioenergies is building a plant to produce its Isonaturane 12 and 16 products, biobased alternatives to petroleum-based isododecane and isohexadecane.
The new plant, recently scaled down to 2,500 tonnes of isobutene derivatives per year (from the previously announced 10,000 t/year), will focus on the most profitable markets: make-up and prestige skincare products.
Global Bioenergies is pleased to announce that it has successfully completed the preliminary design phase of this project for a plant dedicated to the cosmetics market, scheduled to come on stream in mid-2027.
"Two engineering firms were commissioned, the first to handle the biological side of the project, and the second the part dedicated to green chemistry. Their respective expertise gives us a very good vision of the plant's plans. In the short term, we're looking ahead to the next stage, the detailed design phase.says Roland Desvignes, Industrial Director of Global Bioenergies.
At the same time, process validation tests under conditions mimicking those of the future plant, carried out with fermentation specialist ARD at Global Bioenergies' Pomacle-Bazancourt (51) facility, have been successfully completed, according to Global Bioenergies.
"The success of these tests confirms the robustness of our process. They consolidate our business plan and the strong profitability we are projecting for the plant".explains Frédéric Ollivier, Technical Director of Global Bioenergies.
In addition to cosmetics, the plant will also serve to kick-start the market for sustainable aviation fuels (SAF).
Photo: (c) YZ
